PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib

被引：0
|
作者：
Leiping Wang
Qunling Zhang
Jian Zhang
Si Sun
Haiyi Guo
Zhen Jia
Biyun Wang
Zhimin Shao
Zhonghua Wang
Xichun Hu
机构：
[1] Fudan University,Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College
[2] Fudan University,Department of Breast Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College
来源：
BMC Cancer | / 11卷
关键词：
Trastuzumab; Capecitabine; Lapatinib; PI3K Pathway; PIK3CA Mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib
    Wang, Leiping
    Zhang, Qunling
    Zhang, Jian
    Sun, Si
    Guo, Haiyi
    Jia, Zhen
    Wang, Biyun
    Shao, Zhimin
    Wang, Zhonghua
    Hu, Xichun
    BMC CANCER, 2011, 11
  • [2] An evaluation of PI3K pathway activation on the efficacy of both trastuzumab and lapatinib
    Hu, X.
    Wang, L. P.
    Zhang, Q. L.
    Zhang, J.
    Guo, H. Y.
    Sun, S.
    Wang, B. Y.
    Jia, Z.
    Shao, Z. M.
    Wang, Z. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Activated PI3K/AKT confers resistance to trastuzumab but not lapatinib
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2010, 7 (8) : 424 - 424
  • [4] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, Herve
    Castaing, Marine
    Fabre, Monique
    Bosq, Jacques
    Rougemont, Anne-Laure
    Michieis, Stefan
    Vassal, Gilles
    VIRCHOWS ARCHIV, 2007, 451 (02) : 130 - 130
  • [5] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, H.
    Castain, M.
    Fabre, M.
    Bosq, J.
    Rougemont, A.
    Michiels, S.
    Vassal, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Research on drug resistance mechanism of trastuzumab caused by activation of the PI3K/Akt signaling pathway
    Chen, Xi
    Wang, Han
    Ou-yang, Xue-nong
    Xie, Fang-wei
    Wu, Jing-jing
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (04): : 363 - 369
  • [7] Activation of the PI3K/Akt pathway and chemotherapeutic resistance
    West, KA
    Castillo, SS
    Dennis, PA
    DRUG RESISTANCE UPDATES, 2002, 5 (06) : 234 - 248
  • [8] PI3K/AKT pathway activation in bladder carcinogenesis
    Calderaro, Julien
    Rebouissou, Sandra
    de Koning, Leanne
    Masmoudi, Asma
    Herault, Aurelie
    Dubois, Thierry
    Maille, Pascale
    Soyeux, Pascale
    Sibony, Mathilde
    de la Taille, Alexandre
    Vordos, Dimitri
    Lebret, Thierry
    Radvanyi, Francois
    Allory, Yves
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (08) : 1776 - 1784
  • [9] Estrogen receptor alpha activation is mediated by both the MAPK and PI3K phosphorylation pathway in hypoxia
    Park, Joon Woo
    Lee, Youngjoo
    CANCER RESEARCH, 2012, 72
  • [10] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
12345